期刊文献+

人PD-L1Ig融合蛋白的表达及其生物学活性的研究 被引量:5

Expression of Human PD-L1Ig Fusion Protein and Characteristics of Its Bioactivity
下载PDF
导出
摘要 为获取人PD L1Ig融合蛋白 ,研究其对T细胞的调节效应 ,采用PCR法从pMD18 T/PD L1中扩增出人PD L1基因的胞外段序列 ,从人脾脏细胞中扩增出人IgG1Fc恒定区基因 ,两者拼接后插入逆转录病毒载体pEGZ Term ,用脂质体法与两个辅助病毒载体共转染 2 93T包装细胞 ,用含病毒颗粒的培养上清反复感染L92 9细胞 ,Zeocin筛选能稳定分泌人PD L1Ig蛋白的基因转染细胞并亚克隆之 ,经无血清培养 ,收集的上清用Dotblot检测、ELISA定量后 ,浓缩并经ProteinG柱纯化 ,再经Westernblot鉴定。以FACS分析纯化蛋白对活化T细胞表达的PD 1结合能力 ,以体外T细胞活化体系观察其对T细胞表型的调节作用。结果表明 ,成功地构建了表达人PD L1Ig蛋白的重组逆转录病毒载体 ;获得的L92 9/PD L1Ig细胞能稳定分泌人PD L1Ig蛋白 ;该蛋白与PD 1受体具有良好的结合能力 ,能抑制T细胞的进一步活化。 To stably express human PD-L1-Fc fusion protein in eukaryon cells and to investigate the regulatory effet on T cells. Extracellular domain of human PD-L1 gene was amplified by PCR from pMD18-T/PD-L1 vector, and human IgG1(Fc)constant region was obtained through RT-PCR from human spleen cells. Then, assembled by TP-PCR, the derived fragment consisting of the PD-L1ECD and Fc (PD-L1Ig) was inserted into retro virus vector pEGZ-Term to construct the recombinant vector pGEZ-Term/PD-L1Ig. The recombinant vector together with its 2 helper virus vectors was cotransfected into the package cell 293T. The supernatant of 293T containing intact virus granules was used to infect L929 cells. The FCS-free supernatant of infected L929 cells was harvested for subsequent analysis. Confirmed by Dot blot、ELESA and Western blot analysis, the condensed fusion protein was purified through protein G affinity chromatography column. T cells were incubated for 3 days in the wells of plates precoated with PD-L1Ig fusion protein and anti-CD3 mAb to detect its influence on the phenotypes of CD4+ and CD8+ T cells. It was found that recombinant retro virus vector carring human PD-L1Ig fusion gene was constructed successfully and L929/PD-L1Ig cells stably secreting human PD-L1Ig fusion protein were obtained and confirmed. FACS analysis showed its high affinity with its receptor, and the activation of T cells was inhibited obviously by PD-L1Ig in vitro. The construction of cells stably secreting human PD-L1Ig fusion protein and the prepartion of purified protein will contribute to further research on the functions of the gene.
出处 《现代免疫学》 CAS CSCD 北大核心 2004年第6期449-454,共6页 Current Immunology
基金 国家"973"基金资助项目 (2 0 0 1CB5 10 0 3 ) 江苏省高校自然科学研究计划资助项目 (0 3KJB3 2 0 112 0 )
关键词 PD-1 PD-L1 TP-PCR 稳定表达 抑制 PD-1 PD-L1 TP-PCR stable expression inhibition
  • 相关文献

参考文献17

  • 1Bretscher PA,Coln M. A theory of self and non self discrimination[J]. Science,1970,169:1042.
  • 2Lanzavecchia A,Lezzi G,Viola A. From TCR engagement to T cell activation:a kinetic view of T cell behavior[J]. Cell,1999,96:1.
  • 3Chambers CA. The expanding world of co-stimulation:the two-signal model revisited[J]. Trends Immunol,2001,22:217.
  • 4Nimura H,Honjo T. PD-1:an inhibitory immunoreceptor involved in peripheral tolerance[J]. Trends Immunol,2001,22:265.
  • 5Watanabe N,Gavrieli M,Sedy JR,et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1[J]. Nat Immunol,2003,4:670.
  • 6Dong HD,Zhu GF,Tamada K,et al. B7-H1,a third member of the B7 family,co-stimulates T-cell proliferation and interleukin-10 secretion[J]. Nat Med,1999,5:1365.
  • 7Latchman Y, Wood CR, Chernnova T,et al. PD-L2 is a second ligand for PD-1 and inhibit T cell activation[J]. Nat Immunol,2001,2:261.
  • 8Freeman GJ,Long AJ,Iwai Y,et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphcyte activation[J]. J Exp Med,2000,192:1027.
  • 9Carter LL,Fouser LA, Jussif J, et al. PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+T cells and is overcomed by IL-2[J]. Eur J Immunol,2002,32:634.
  • 10Dong HD,Strome SE,Salomao DR,et al. Tumor-associated B7-H1 promotes T-cell apoptosis:a potential mechanism of immune evasion[J]. Nat Med,2002,8:793.

同被引文献40

  • 1张光波,陈永井,姜智,於葛华,杨明峰,施勤,王勤,李文香,张学光.人B7-H3基因转染及其生物学功能的研究[J].现代免疫学,2004,24(6):455-459. 被引量:9
  • 2孙中文,陶然,陆艳红,石云杰,於葛华,邱玉华,张学光.5株鼠抗人CD28单克隆抗体的研制及生物学特性的研究[J].中国免疫学杂志,2005,21(6):406-410. 被引量:11
  • 3饶爱华,周迎会,陈永井,马震宇,张学光.一株新的鼠抗人2IgB7-H3功能性单克隆抗体的研制及其生物学特性的鉴定[J].现代免疫学,2006,26(4):278-282. 被引量:2
  • 4HelmyKY, KatschkeKJJr, GorganiNN, etal. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens[J]. Cell, 2006, 124:915-927.
  • 5Vogt L, Schmitz N, Kurrer MO, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell acti vation[J]. J Clin Invest, 2006, 116:2817-2826.
  • 6Lee MY, Kim WJ, Kang YJ, et al. Z39Ig is expressed on maerophages and may mediate inflammatory reactions in arthritis and atherosclerosis[J]. J Leukoc Biol, 2006, 80:922-928.
  • 7Kim JK, Choi EM, Shin HI, et al. Characterization of monoclonal antibody specific to the Z39Ig protein, a member of immunoglobulin superfamily[J].Immunol Lett, 2005, 99:153-161.
  • 8Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited[J]. Annu Rev Immunol, 2005, 23:515-548.
  • 9Rietz C, Chen L. New B7 family members with positive and negative costimulatory function [ J ]. Am J Transplant, 2004, 4:8-14.
  • 10Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function[J]. Nat Immunoh 2001, 2:203-209.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部